Malignant Liver Lesions on MRI
Content Reviewed: 2021-12-26
2.5 CME
38 Videos
51 Clinical Cases
2.5 CME
Course Description
Dr. Mathur's latest course on Malignant Liver Lesions covers the 6 most common causes of cancer- malignant liver lesions.
Learning Outcomes & CME Information
SA-CME now available! In addition to earning AMA PRA Category 1 Credit(s)™, this course is eligible for SA-CME credit. Note: the course evaluation must be completed and SA-CME selected in order to claim SA-CME credit.
After completing this course, you will be better able to:
- Apply appropriate search patterns to ensure high quality case assessment
- Identify key anatomical landmarks, variations, and abnormalities on imaging
- Accurately interpret advanced imaging cases
- Formulate definitive diagnoses and limited differentials
Instructors
Mahan Mathur, MD
Associate Professor, Division of Body Imaging; Vice Chair of Education, Dept of Radiology and Biomedical Imaging
Yale School of Medicine
Lesson
Malignant Liver Lesions Pre-Course Activities
1 Clinical Cases
5 min.
Lesson
Introduction and Anatomy
2 Clinical Cases
13 min.
Lesson
Malignant Liver Lesion Case Review
49 Clinical Cases
2 hr. 11 min.
Morphologic Cirrhosis
5 m.
Non-Malignant Nodules in the Cirrhotic Liver
2 m.
Dysplastic Nodules
4 m.
Portal Hypertension – 2 Patient Case Review
4 m.
Pseudocirrhosis
3 m.
LI-RADS – Summary
12 m.
LI-RADS 1 or 2
3 m.
LI-RADS 3
3 m.
LI-RADS 3 (THID)
3 m.
LI-RADS 4
3 m.
LI-RADS 3 Upgraded to LI-RADS 4
4 m.
LI-RADS 5
3 m.
LI-RADS 5 Change in Lesion Overtime
4 m.
LI-RADS 5 – Non-peripheral Washout (NPWO)
3 m.
LI-RADS 4 – Psuedo Capsule
4 m.
LI-RADS 3 – No Ancillary Imaging Findings
3 m.
LI-RADS 5 – Size, Psuedo Capsule, & NPWO
3 m.
LI-RADS 5 – 22mm with NPWO
3 m.
LI-RADS 4 – Greater than 20mm, Lacking Ancillary Features
4 m.
LI-RADS 5 – All-qualifiers, HCC
4 m.
LI-RADS – Tumor in Vein (TIV)
6 m.
LI-RADS – TIV Infiltrative Tumor
4 m.
LI-RADS M – Metastatic Urothelial Cancer
5 m.
Fibrolamellar Hepatocellular Carcinoma (FHCC)
6 m.
Treatment Options
9 m.
Successfully Treated LI-RADS 5
4 m.
Successfully treated LI-RADS 5, with Recurrence
4 m.
2 Lesions Treated with Transarterial Embolization
4 m.
Partially Successful TASE
3 m.
Recurrence in a Patient Treated with Radioembolization (Y-90)
4 m.
2 Patients with Cholangiocarcinoma
8 m.
Hypervascular Mets
4 m.
Hypovascular Metastasis from Breast Cancer
4 m.
Mucinous Liver Metastasis
4 m.
Hypovascular Metastasis Post-op
4 m.
Course Evaluation
© 2023 MRI Online. All Rights Reserved.